OC
TYRA icon

Oppenheimer & Co’s Tyra Biosciences TYRA Stock Holding History

Oppenheimer & Co’s Portfolio TYRA Stock Details TYRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.68M Sell
83,783
-409
-0.5% -$13.5K 0.03% 554
2026
Q1 		$3.22M Sell
84,192
-534
-0.6% -$17.3K 0.04% 448
2025
Q4 		$2.23M Buy
84,726
+2,488
+3% +$45.7K 0.03% 517
2025
Q3 		$1.15M Buy
82,238
+8,205
+11% +$93.6K 0.01% 828
2025
Q2 		$708K Sell
74,033
-772
-1% -$7.33K 0.01% 1008
2025
Q1 		$696K Sell
74,805
-634
-0.8% -$8.2K 0.01% 955
2024
Q4 		$1.05M Sell
75,439
-1,367
-2% -$24.8K 0.02% 765
2024
Q3 		$1.81M Buy
76,806
+6,318
+9% +$133K 0.03% 588
2024
Q2 		$1.13M Buy
70,488
+10,912
+18% +$188K 0.02% 727
2024
Q1 		$977K Buy
+59,576
New +$977K 0.02% 747

Other funds holding TYRA

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
APMC
Alta Partners Management Company Jackson, Wyoming $127M AUM 230.85% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
CC
Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return

Oppenheimer & Co's TYRA Position: Q2 2026 in Review

Oppenheimer & Co reduced its Tyra Biosciences (TYRA) stake by 0.49% in Q2 2026, selling an estimated $13.5K and leaving 83,783 shares worth $2.68M. The position accounts for 0.03% of the portfolio, ranked #554.

Oppenheimer & Co first reported a position in TYRA in Q1 2024 and has held it in 10 quarters since. The position peaked at $3.22M in Q1 2026. 168 funds tracked by Wall St. Rank hold TYRA as of Q2 2026.

  • Oppenheimer & Co held 83,783 shares of Tyra Biosciences worth $2.68M as of Q2 2026.
  • Oppenheimer & Co sold 409 Tyra Biosciences shares in Q2 2026, an estimated $13.5K.
  • Tyra Biosciences made up 0.03% of Oppenheimer & Co's portfolio in Q2 2026, its #554 holding.
  • Oppenheimer & Co first reported a position in Tyra Biosciences in Q1 2024 and has held it in 10 quarters since.
  • Oppenheimer & Co's Tyra Biosciences position peaked at $3.22M in Q1 2026.
  • 168 funds tracked by Wall St. Rank held Tyra Biosciences as of Q2 2026.

Based on Oppenheimer & Co's 13F filing for Q2 2026, filed 3 Aug 2026.